Image

SynKIR-310 for Relapsed/Refractory B-NHL

Join a trial for SynKIR-310 for tough B-NHL cases.

Recruiting
18 years and older
All
Phase 1
  • Simplified description (AI rewritten)
  • Technical description (Original)

This study is testing a new treatment called SynKIR-310 for people with a type of cancer called B-NHL (B-cell Non-Hodgkin Lymphoma). It is for those whose cancer has come back or didn't respond after trying other treatments. Participants will receive one IV dose (medicine given through a vein) to see if it is safe and works well. The study will include up to 18 people and will take place in different centers. Two groups will first try different doses to find the best one for future studies. Once the best dose is found, more people will join to help learn more about how the treatment works.

  • The study involves a single infusion of SynKIR-310.
  • Participants must be 18 or older and have tried at least two other treatments.
  • Cannot have certain health issues like uncontrolled infections or heart problems.
Print
Study details
    B Cell Lymphoma
    NHL
    Adult
    Mantle Cell Lymphoma
    Relapsed Non-Hodgkin Lymphoma
    Refractory Non-Hodgkin Lymphoma
    Aggressive B-Cell Non-Hodgkin Lymphoma
    Indolent B-Cell Non-Hodgkin Lymphoma
    Follicular Lymphoma
    Marginal Zone Lymphoma
    DLBCL - Diffuse Large B Cell Lymphoma
    HGBL With MYC and BCL2 and/or BCL6 Rearrangements
    High-grade B-cell Lymphoma
    Diffuse Large B Cell Lymphoma
    Large B-cell Lymphoma
    T-Cell/Histiocyte Rich Lymphoma
    Non-hodgkin Lymphoma
    B Cell
    Primary Mediastinal Large B-cell Lymphoma (PMBCL)
    Epstein-Barr Virus Positive DLBCL
    Nos
    Follicular Lymphoma Grade 3B
    DLBCL (Diffuse Large B-Cell Lymphoma) Associated With Chronic Inflammation
    High Grade B-Cell Lymphoma
    Not Otherwise Specified
    Follicular Lymphoma Grade 3
    Marginal Zone Splenic Lymphoma
    DLBCL

NCT06544265

Verismo Therapeutics

7 March 2026

Contact a study center
Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Race
Ethnicity
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.